Literature DB >> 36210393

Farnesoid X receptor regulates PI3K/AKT/mTOR signaling pathway, lipid metabolism, and immune response in hybrid grouper.

Jia Xu1, Xinzhou Yao1, Xiaoyue Li1, Shiwei Xie2,3,4,5, Shuyan Chi1,6,7, Shuang Zhang1,6,7, Junming Cao1,6,7, Beiping Tan8,9,10.   

Abstract

Some diseases related to lipid metabolism increase yearly in cultured fish, and the farnesoid X receptor (FXR) is a nuclear protein that plays a key role in inflammatory responses and lipid metabolism. However, the roles of FXR in hybrid grouper (Epinephelus fuscoguttatus♀ × E. lanceolatus♂) remain poorly understood. The main objective of this study was to explore the roles of hepatic FXR in triggering the immune response and the potential functions of FXR in regulating the lipid metabolism. In the present study, the full-length sequence of fxr from hybrid grouper was cloned and characterized for the first time. Upon the Vibrio parahaemolyticus stimulation, the transcriptional level of fxr was rapidly elevated in the head kidney tissue in the early stage of infection. In vivo and vitro, activation of FXR by obeticholic acid (OA) significantly increased the concentrations and mRNA levels of hepatic inflammatory cytokines. These effects were inversed when FXR was inhibited by guggulsterone (GU). Moreover, the activation of FXR to suppress the PI3K/AKT/mTOR signaling pathway improves hepatic lipid metabolism and reduces hepatic lipid accumulation in vivo and vitro. In addition, the inhibition of FXR activated the PI3K/AKT/mTOR pathway, decreased the lipolysis and increased the lipogenesis, and subsequently increased the lipid accumulation in fish. These results revealed the positive roles of FXR in triggering immune responses and improving lipid metabolism and accumulation in hybrid grouper.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Farnesoid X receptor; Fish; Inflammatory responses; Lipid accumulation; PI3K/AKT/mTOR

Year:  2022        PMID: 36210393     DOI: 10.1007/s10695-022-01130-z

Source DB:  PubMed          Journal:  Fish Physiol Biochem        ISSN: 0920-1742            Impact factor:   3.014


  34 in total

1.  Activation of the Farnesoid X Receptor (FXR) Suppresses Linoleic Acid-Induced Inflammation in the Large Yellow Croaker (Larimichthys crocea).

Authors:  Jianlong Du; Qiang Chen; Yongnan Li; Xiaojun Xiang; Wei Xu; Kangsen Mai; Qinghui Ai
Journal:  J Nutr       Date:  2020-09-01       Impact factor: 4.798

Review 2.  Functions of autophagy in normal and diseased liver.

Authors:  Mark J Czaja; Wen-Xing Ding; Terrence M Donohue; Scott L Friedman; Jae-Sung Kim; Masaaki Komatsu; John J Lemasters; Antoinette Lemoine; Jiandie D Lin; Jing-hsiung James Ou; David H Perlmutter; Glenn Randall; Ratna B Ray; Allan Tsung; Xiao-Ming Yin
Journal:  Autophagy       Date:  2013-05-22       Impact factor: 16.016

3.  Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression.

Authors:  Thierry Claudel; Yusuke Inoue; Olivier Barbier; Daniel Duran-Sandoval; Vladimir Kosykh; Jamila Fruchart; Jean-Charles Fruchart; Frank J Gonzalez; Bart Staels
Journal:  Gastroenterology       Date:  2003-08       Impact factor: 22.682

Review 4.  Targeting farnesoid X receptor for liver and metabolic disorders.

Authors:  Stefano Fiorucci; Gianni Rizzo; Annibale Donini; Eleonora Distrutti; Luca Santucci
Journal:  Trends Mol Med       Date:  2007-06-27       Impact factor: 11.951

5.  Molecular cloning and characterization of farnesoid X receptor from large yellow croaker (Larimichthys crocea) and the effect of dietary CDCA on the expression of inflammatory genes in intestine and spleen.

Authors:  Jianlong Du; Xiaojun Xiang; Yongnan Li; Renlei Ji; Hanlin Xu; Kangsen Mai; Qinghui Ai
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2017-10-03       Impact factor: 2.231

6.  Effects of Farnesoid X Receptor Activation on Arachidonic Acid Metabolism, NF-kB Signaling, and Hepatic Inflammation.

Authors:  Zhibo Gai; Michele Visentin; Ting Gui; Lin Zhao; Wolfgang E Thasler; Stephanie Häusler; Ivan Hartling; Alessio Cremonesi; Christian Hiller; Gerd A Kullak-Ublick
Journal:  Mol Pharmacol       Date:  2018-05-09       Impact factor: 4.436

7.  FXR and TGR5 Agonists Ameliorate Liver Injury, Steatosis, and Inflammation After Binge or Prolonged Alcohol Feeding in Mice.

Authors:  Arvin Iracheta-Vellve; Charles D Calenda; Jan Petrasek; Aditya Ambade; Karen Kodys; Luciano Adorini; Gyongyi Szabo
Journal:  Hepatol Commun       Date:  2018-10-15

8.  Integrative Transcriptomic and Small RNA Sequencing Reveals Immune-Related miRNA-mRNA Regulation Network for Soybean Meal-Induced Enteritis in Hybrid Grouper, Epinephelus fuscoguttatus♀ × Epinephelus lanceolatus♂.

Authors:  Yuanfa He; Guanlin Ye; Shuyan Chi; Beiping Tan; Xiaohui Dong; Qihui Yang; Hongyu Liu; Shuang Zhang
Journal:  Front Immunol       Date:  2020-08-06       Impact factor: 7.561

9.  Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid.

Authors:  Gideon M Hirschfield; Andrew Mason; Velimir Luketic; Keith Lindor; Stuart C Gordon; Marlyn Mayo; Kris V Kowdley; Catherine Vincent; Henry C Bodhenheimer; Albert Parés; Michael Trauner; Hanns-Ulrich Marschall; Luciano Adorini; Cathi Sciacca; Tessa Beecher-Jones; Erin Castelloe; Olaf Böhm; David Shapiro
Journal:  Gastroenterology       Date:  2014-12-11       Impact factor: 22.682

10.  Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism.

Authors:  Fengjie Huang; Xiaojiao Zheng; Xiaohui Ma; Runqiu Jiang; Wangyi Zhou; Shuiping Zhou; Yunjing Zhang; Sha Lei; Shouli Wang; Junliang Kuang; Xiaolong Han; Meilin Wei; Yijun You; Mengci Li; Yitao Li; Dandan Liang; Jiajian Liu; Tianlu Chen; Chao Yan; Runmin Wei; Cynthia Rajani; Chengxing Shen; Guoxiang Xie; Zhaoxiang Bian; Houkai Li; Aihua Zhao; Wei Jia
Journal:  Nat Commun       Date:  2019-10-31       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.